Inter-rater agreement of HER2-low scores between expert breast pathologists and the Visiopharm digital image analysis application (HER2 APP, CE2797). - Parry S; Zabaglo L; Shaaban AM; Dodson A (The journal of pathology. Clinical research, 2025)